SINGAPORE] Many pharmaceutical companies are waiting for confirmation from the US administration on whether their expansion plans qualify them for tariff exemptions, Minister of State for Trade and Industry Gan Siow Huang said in Parliament on Tuesday (Oct 14). On Sep 25, the US announced a 100 per cent tariff on branded or patented pharmaceutical products with effect from Oct 1, unless companies are building manufacturing plants in the US. “The implementation of this tariff has since been delayed to allow time for pharmaceutical companies to negotiate exemptions with the US administration,” Gan noted. Of pharmaceutical companies based in Singapore, many “have plans to build new capacity or expand their existing facilities in the US, and are awaiting further details from the US administration to confirm that their plans would qualify for the tariff exemption”.   https://www.businesstimes.com.sg/singapore/singapore-based-pharma-companies-waiting-confirmation-us-tariff-exemptions-mti (ICE SINGAPORE)

Fonte notizia: The Business Times, 14 October 2025